Bone-targeted agents in multiple myeloma

by Nishida, Hiroko
Published in Hematol Rep (2018)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review

by Nishida, Hiroko
Published in Cancers (Basel) (2021)

Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets

by Nishida, Hiroko, Yamada, Taketo
Published in J Oncol (2019)

Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission

by Nishida, Hiroko, Suzuki, Hiroshi, Hori, Masao, Obara, Katsuyuki
Published in Leuk Res Rep (2018)

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma

by Nishida, Hiroko, Hayashi, Mutsumi, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Published in Blood Cancer J (2018)

The Assembly and Maintenance of Heterochromatin Initiated by Transgene Repeats Are Independent of the RNA Interference Pathway in Mammalian Cells

by Wang, Fangwei, Koyama, Naoki, Nishida, Hiroko, Haraguchi, Tokuko, Reith, Walter, Tsukamoto, Toshiro
Published 2006

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

by Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Published in Cancer Cell Int (2016)

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synt...

by Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yanagawa, Hiroshi, Yamada, Taketo
Published in Cancers (Basel) (2019)

Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription

by Yamada, Kohji, Hayashi, Mutsumi, Madokoro, Hiroko, Nishida, Hiroko, Du, Wenlin, Ohnuma, Kei, Sakamoto, Michiie, Morimoto, Chikao, Yamada, Taketo
Published 2013